Get In Touch

Pediatric asthma is chronic inflammation of the airways characterized by an obstruction of airflow. It is the most common chronic illness found in children and infants and is not easily detectable. The symptoms of pediatric asthma include a whistling sound while breathing, rapid & labored breathing, chest pain, coughing, and less energy or feeling of tiredness. A few children experience asthma when they perform any physical activity. This is known as exercise-induced bronchospasm. Pediatric asthma has no cure but is controllable through the right medications and treatment plan to further prevent lung damage. However, in some children, unmanaged asthma can lead to fatal asthma attacks. Risk factors that lead to the development of childhood asthma are allergies, low birth weight, family history of allergies or asthma, and others. As estimated by the World Health Organization (WHO), there were 383,000 deaths worldwide due to asthma. Currently, there are 235 million patients suffering from asthma globally. The causes of pediatric asthma are unknown, however an overly sensitive immune system could be a risk factor. A sensitive immune system leads to the swelling of lungs and airways, which further generate mucus when exposed to triggers owing to allergies of dust, pollen, air pollutants, viral infections, and physical activities. Pediatric asthma is incurable, however it can be prevented through regular monitoring, limiting smoking around children, controlling heartburn, and other factors. 

The global pediatric asthma treatment market is driven by an increase in the incidence of asthma, rise in allergy cases, availability of advanced inhaler devices and innovative biological drugs, and growing pollution levels. Also, increase in awareness about the diagnosis of asthma and improving health care facilities are likely to drive the market. Technological advancement is a major factor in the treatment of pediatric patients. Advanced monitoring devices manage pediatric asthma and help in controlling the condition. As estimated by the American Lung Association, the Centers for Disease Control and Prevention (CDC), and the National Institute of Allergy and Infectious Diseases (NIAID), 6 million children are affected by asthma currently. Approvals of new therapies are also a driving factor for the global pediatric asthma treatment market. However, patent expiry of drugs, increase in preference for generic drugs, and high cost of pediatric asthma treatment are estimated to restrain the global pediatric asthma treatment market. Increase in mergers and acquisitions, collaborations, and partnerships; rise in the popularity of combination therapies; and new product launches are estimated to offer investment opportunities to companies operating in the global pediatric asthma treatment market. 

The global pediatric asthma treatment market can be segmented based on product, route of administration, end-user, and region. Based on product, the global pediatric asthma treatment market can be bifurcated into drug class and inhaled medication devices. The drug class segment can be further divided into long-term control medications, quick-relief medications, and others. The long-term medication sub-segment can be further segmented into inhaled corticosteroids, leukotriene modifiers, combination inhalers, and theophylline. The quick relief medications sub-segment can be further categorized into short-acting beta agonists, ipratropium (Atrovent HFA), oral and intravenous corticosteroids, and immunomodulatory agents. The others sub-segment can be further divided allergy medications, omalizumab (Xolair), and allergy shots (immunotherapy). Inhaled devices consist of a measured dose of medicines. The inhaled devices segment can be further classified into pressurized metered dose inhalers, autohalers (dry powder inhalers), nebulizers, and accuhalers & turbuhalers. Metered dose inhalers are the most commonly used devices. In terms of route of administration, the global market can be categorized into oral route, nasal route, and parenteral route. Based on end-user, the global pediatric asthma treatment market can be classified into hospitals, clinics, home care, and others. 

In terms of region, the global pediatric asthma treatment market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The pediatric asthma treatment market in North America is likely to be propelled by developed health care infrastructure, innovative drugs, technologically advanced asthma treatment, and increase in the number of asthma patients in the region. North America accounts for a dominant market share, followed by Europe and Asia Pacific. The market in Asia Pacific is expected to expand at at rapid rate, owing to a rise in the number of asthma patients, environmental changes, increase in disposable income, and developing health care infrastructure in the region. 

Major players operating in the global pediatric asthma treatment market are GlaxoSmithKline plc, Pfizer Inc., AstraZeneca, Boehringer Ingelheim International GmbH, OPKO Health, Medisol Lifescience Pvt. Ltd, Teva Pharmaceutical Industries Ltd., and others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Pediatric Asthma Treatment Market